A detailed history of Intech Investment Management LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Intech Investment Management LLC holds 46,984 shares of NEO stock, worth $795,439. This represents 0.01% of its overall portfolio holdings.

Number of Shares
46,984
Previous 30,300 55.06%
Holding current value
$795,439
Previous $420,000 65.0%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$13.4 - $17.73 $223,565 - $295,807
16,684 Added 55.06%
46,984 $693,000
Q2 2024

Aug 12, 2024

BUY
$13.01 - $15.77 $394,203 - $477,831
30,300 New
30,300 $420,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.13B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.